ÃØÃÜÑо¿Ëù

Internal Server Error
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!
Signup and get free access

Last updated:

About Frazier Life Sciences

Frazier Life Sciences is a venture capital firm founded in 2005. It is primarily based out of Palo Alto, United States. As of Apr 2025, Frazier Life Sciences is an active investor, having invested in 49 companies, with 10 new investments in the last 12 months. It primarily invests in Series C round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it led the $67.5M Series A round of Alesta Therapeutics along with Novartis Venture Fund. This round also saw participation from RTW Investments and other investors.
Overall, Frazier Life Sciences portfolio has seen 16 IPOs and 14 acquisitions including key companies like Chimerix, Cidara Therapeutics and Maze Therapeutics. A lot of funds co-invest with Frazier Life Sciences, with names like Deep Track Capital sharing a substantial percentage of its portfolio.
Frazier Life Sciences has team of 54 people including 8 partners.
Key Metrics
Team Members
, &
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series A, Series B &
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Deals in last 12 months
Get Frazier Life Sciences' portfolio delivered to your inbox!

Frazier Life Sciences' Investment Trends by Stage

Frazier Life Sciences has made 5 investments in Series A stage, 4 investments in Series B stage, 4 investments in Series C stage, 2 investments in Post IPO stage and 2 investments in Series D stage.
Here are Frazier Life Sciences' investment trends by stages:
Note: We have considered here, only first round of investments
Breakdown of Frazier Life Sciences' investments by stage of entrySeries A (5)Series B (4)
Stage of entry
No. of Investments
Series A
5
Series B
4
Series C
4
Post IPO
2
Series D
2

Frazier Life Sciences' Investment Trends by Sector

Frazier Life Sciences has a diverse portfolio, with companies operating in the Life Sciences, High Tech, HealthTech, Healthcare and Sustainability Tech. Notably, it has invested in 46 Tech companies, 40 Enterprise (B2B) companies and 1 Consumer (B2C) company.
Here are Frazier Life Sciences' investment trends by sector:
Note: We have considered here, only first round of investments
Breakdown of Frazier Life Sciences' investments by sectorsLife Sciences (16)High Tech (2)
Sector
No. of Investments
Life Sciences
16
High Tech
2
HealthTech
1
Healthcare
1
Sustainability Tech
1

Frazier Life Sciences' Investment Trends by Geography

Frazier Life Sciences has made most investments in United States (41), followed by Netherlands where it has made 3 investments.

Frazier Life Sciences' recent investments

Frazier Life Sciences has made 2 investments in 2025 so far - Attovia and Alesta Therapeutics.
Here are the most recent investments by Frazier Life Sciences:
Date
Company
Location
Round Details
Round Amount
Co-Investors
Apr 15, 2025
United States
Series C
$90M
Jan 08, 2025
Netherlands
Series A
$67.5M
Dec 04, 2024
United States
Series D
$115M
Nov 12, 2024
Switzerland
Series D
$181M
Orbimed [+6]
Oct 23, 2024
United States
Series C
$175M
[+12]
lockGet the detailed list of all investments by Frazier Life Sciences. Download now!

IPOs and Publicly Listed companies in Frazier Life Sciences' Portfolio

16 of Frazier Life Sciences' portfolio companies have become public.ÌýMaze Therapeutics got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jan 2025 at marketcap of $700MÌýand MBX Biosciences got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $510M.
Here are Frazier Life Sciences' portfolio companies that went public:
Company
IPO Date
First Invested on
First Round of Investment
Round Size
Jan 31, 2025
Dec 04, 2024
Series D
$115M
Sep 13, 2024
Aug 05, 2024
Series C
$63.5M
Nov 11, 2022
-
-
-
Feb 08, 2021
-
-
-
Apr 24, 2020
Jul 05, 2023
Post IPO
$85M

Acquired companies in Frazier Life Sciences' Portfolio

14 companies from Frazier Life Sciences' portfolio have been acquired.ÌýThe most recent acquisition were Chimerix in Mar 2025Ìýby Jazz Pharmaceuticals for $935M.
Here are Frazier Life Sciences' portfolio companies that got acquired most recently:
Company
Acquisition Date
First Invested on
First Round of Investment
Round Size
Mar 05, 2025
-
-
-
Apr 10, 2024
-
-
-
Mar 25, 2024
-
-
-
Jan 05, 2024
-
-
-
Jun 12, 2023
-
-
-

Team profile of Frazier Life Sciences

Frazier Life Sciences has a team of 54 membersÌýincluding 8 Partners, 15 Venture Partners and 4 PrincipalsÌýlocated in United States and United Kingdom. Frazier Life Sciences' team does not sit on the board of any company as of now.
Here is a list of top team members in Frazier Life Sciences:
Name
Designation
Location
Board Memberships
Contact details
Partner
Menlo Park
-
Partner
Menlo Park
-
-
Partner
San Diego
-
-
Partner
Los Altos
-
-
Partner
Menlo Park
-
Partner
Bellevue
-
Partner
Haslett
-
Partner
Seattle
-
Venture Partner
Seattle
-
Venture Partner
Seattle
-
-
Venture Partner
New York City
-
-
lockGet the full list of Frazier Life Sciences' team & partners for free. Download now!

Co-investors of Frazier Life Sciences

Over the past 4 years, 177 investors have co-invested in Frazier Life Sciences's portfolio companies.

  • Invested before Frazier Life Sciences:ÌýCasdin Capital, Orbimed and 95 others have invested in rounds before Frazier Life Sciences. There are 3 companies where Casdin Capital has invested before Frazier Life Sciences and 3 companies where Orbimed has invested before Frazier Life Sciences.
  • Top Co-investors of Frazier Life Sciences:Ìý64 investors entered a company along with Frazier Life Sciences. These include investors like Deep Track Capital (4 companies).
  • Invested after Frazier Life Sciences:ÌýA total of 16 investors have invested in Frazier Life Sciences's portfolio after their investments. Top Investors include Nextech Systems (1 company), Venrock (1 company) and Deep Track Capital (1 company).
Get full list of Frazier Life Sciences' co-investors delivered to your inbox!

Recent News related to Frazier Life Sciences

•
Business Wire•Apr 17, 2025•Frazier Life Sciences
•
GEN•Apr 16, 2025•Frazier Life Sciences, Attovia
•
intelligence360•Apr 07, 2025•Droia Ventures, Frazier Life Sciences, Novo Holdings, LifeArc Ventures and 1 other
•
Business Wire•Apr 01, 2025•Frazier Life Sciences
•
PR Newswire•Mar 25, 2025•, Droia Ventures, Frazier Life Sciences, Novo Holdings and 3 others
•
Business Wire•Mar 19, 2025•Frazier Life Sciences
•
intelligence360•Mar 17, 2025•, Frazier Life Sciences, Jeito, Novo Holdings and 7 others
•
Business Wire•Mar 06, 2025•Frazier Life Sciences
•
Pharmaceutical Technology•Mar 04, 2025•, Frazier Life Sciences, Jeito, Omega Funds and 3 others
•
Jinglingshuju•Mar 04, 2025•, Frazier Life Sciences, Jeito, Novo Holdings and 6 others
Unlock full details of this profile with our freeÌýLiteÌý±è±ô²¹²Ô!Signup and get free accessÌýarrow-right-long